Eichberg DG, Achua JK, Locatelli E, Shah AH, Komotar RJ, Ghods AJ
GI Adverse Events with GLP-1 Receptor Agonists for Weight Loss: Understanding the Risks Philip Schoenfeld, MD, MSEd, MSc (Epi) 1 and Sonali Paul, MD, MS 2 1 2 1 Chief (Emeritus), Gastroenterology Section, John D
Specifically, the HR for major depressive disorder is 2.95 (95% CI 2.823.08), for anxiety 2.08 (95% CI 2.042.12), and for suicidal ideations or attempts 2.06 (95% CI 1.922.21), further demonstrating the significant association with GLP-1 RA treatment over time
10.1074/jbc.M700885200 70 LuW.CheX.QuX.ZhengC.YangX.BaoB.et al (2021)
significantly more than in other groups (0%)] failed to achieve criterion in the acquisition phase and received a maximal score of 60
GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis